Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was up 10.6% during mid-day trading on Thursday . The stock traded as high as GBX 1.88 ($0.02) and last traded at GBX 1.88 ($0.02). Approximately 316,769 shares changed hands during trading, a decline of 74% from the average daily volume of 1,235,528 shares. The stock had previously closed at GBX 1.70 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market cap of £7.53 million, a price-to-earnings ratio of -194.00 and a beta of 0.38. The firm has a 50-day moving average price of GBX 2 and a two-hundred day moving average price of GBX 1.83.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- How to Use the MarketBeat Stock Screener
- Tesla Investors Continue to Profit From the Trump Trade
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- How to Start Investing in Real Estate
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
